Amphotericin B liposomal less toxic than lipid complex formulation

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2001年 / 835卷 / 1期
关键词：
Febrile Neutropenia; Liposomal Amphotericin; Lipid Complex; Lipid Formulation; AmBisome;
D O I：
10.2165/00128415-200108350-00010
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [41] PHARMACOLOGY AND TOXICOLOGY OF A LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN RODENTS
    PROFFITT, RT
    SATORIUS, A
    CHIANG, SM
    SULLIVAN, L
    ADLERMOORE, JP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 : 49 - 61
  • [42] PEGylated liposomal formulation of amphotericin B for improved treatment of cutaneous lesihmaniasis
    Ramos, Guilherme Santos
    Carregal, Virginia Mendes
    Marques Borges, Gabriel Silva
    Fujiwara, Ricardo Toshio
    Miranda Ferreira, Lucas Antonio
    Goulart Guimaraes, Pedro Pires
    Georges Frezard, Frederic Jean
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1341 - 1341
  • [43] Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
    Jaafari, Mahmoud Reza
    Hatamipour, Mahdi
    Alavizadeh, Seyedeh Hoda
    Abbasi, Azam
    Saberi, Zahra
    Rafati, Sima
    Taslimi, Yasaman
    Mohammadi, Akram Miramin
    Khamesipour, Ali
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2019, 11 : 156 - 165
  • [44] Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B
    Amato, Valdir Sabbaga
    Tuon, Felipe Francisco
    Campos, Aleia
    Bacha, Helio Arthur
    Nicodemo, Antonio Carlos
    Neto, Vicente Amato
    Shikanai-Yasuda, Maria Aparecida
    CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) : 311 - 312
  • [45] Guidelines for the reconstitution of the correct amphotericin B lipid formulation
    Keady, Simon
    Panesar, Preet
    Damianos, Janet
    EJHP PRACTICE, 2010, 16 (03): : 78 - 80
  • [46] Role of the lipid formulation of amphotericin B in pediatric oncohematology
    Leverger, G
    PRESSE MEDICALE, 2000, 29 (22): : 1266 - 1267
  • [47] Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B
    Denning, DW
    Warn, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (11) : 2592 - 2599
  • [48] Liposomal Amphotericin B Formulation Displaying Lipid-Modified Chitin-Binding Domains with Enhanced Antifungal Activity
    Taniguchi, Hiromasa
    Ishimime, Yugo
    Minamihata, Kosuke
    Santoso, Pugoh
    Komada, Takuya
    Saputra, Hendra
    Uchida, Kazuki
    Goto, Masahiro
    Taira, Toki
    Kamiya, Noriho
    MOLECULAR PHARMACEUTICS, 2022, : 3906 - 3914
  • [49] CLINICAL USE OF LIPOSOMAL AND LIPID-COMPLEXED AMPHOTERICIN-B
    DEMARIE, S
    JANKNEGT, R
    BAKKERWOUDENBERG, IAJM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 33 (05) : 907 - 916
  • [50] Comparative Efficacies of Lipid-Complexed Amphotericin B and Liposomal Amphotericin B against Coccidioidal Meningitis in Rabbits
    Clemons, Karl V.
    Capilla, Javier
    Sobel, Raymond A.
    Martinez, Marife
    Tong, Ann-Jay
    Stevens, David A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 1858 - 1862
12345